# US 2018/0023131 A1 · Methods to amplify highly uniform and less error prone nucleic acid libraries

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0023131 A1
- Document ID: US20180023131A1
- Status: Published application
- Kind: A1
- Application number: 15/723,015
- Filed: 2017-10-02
- Published: 2018-01-25
- Earliest claimed: 2015-03-30
- Assignees: Roche Sequencing Solutions, Inc.
- Applicants: Roche Sequencing Solutions, Inc.
- Inventors: Brian Christopher Godwin
- Web page: https://patentgrep.com/patent/US20180023131A1

## CPC

- C12Q 1/6853: using modified primers or templates
- C12N 15/1093: {General methods of preparing gene libraries, not provided for in other subgroups}
- C12Q 1/6855: Ligating adaptors
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to a kit and a method of linear amplification of a least one nucleic acid target in a sample, said method comprising: (a) contacting each target in the sample with a nucleic acid polymerase and a primer comprising a component preventing copying of the primer by the nucleic acid polymerase; and at least one nuclease blocking nucleotide; (b) generating a primer extension product; (c) preventing priming by the 3′-end of the primer extension product, and (d) repeating steps b) and c) at least once.

## Claims

### Claim 1

A method of linear amplification of a least one nucleic acid target in a sample comprising:
(a) contacting each target in the sample with a nucleic acid polymerase and a primer comprising
a component preventing copying of the primer by the nucleic acid polymerase; and
at least one nuclease blocking nucleotide;
(b) generating a primer extension product;
(c) preventing priming by the 3′-end of the primer extension product
(d) repeating steps b) and c) at least once.

### Claim 2 (depends on 1)

The method of claim 1, wherein the component preventing copying of the primer by the nucleic acid polymerase is a precursor of a quadruplex-forming sequence.

### Claim 3 (depends on 1)

The method of claim 1, wherein the component preventing copying of the primer by the nucleic acid polymerase is a nucleic acid modification selected from modified base, modified nucleotide, or a modified backbone.

### Claim 4 (depends on 1)

The method of claim 1, wherein the preventing priming step comprises contacting the primer extension product with a non-extendable oligonucleotide complementary to a sequence comprising the 3′-end of the primer extension product.

### Claim 5 (depends on 1)

The method of claim 1, wherein the preventing priming step comprising forming a hairpin by the 3′-end of the primer extension product.

### Claim 6 (depends on 1)

The method of claim 1, further comprising a step of increasing the rate of step (b).
by contacting the sample with a facilitating enzyme selected from recombinase, helicase, exonuclease and an endonuclease.

### Claim 7 (depends on 1)

The method of claim 1, wherein the exonuclease block is a phosphorothioate modification of one or more nucleotides in the primer.

### Claim 8 (depends on 1)

The method of claim 1, further comprising a preliminary step of ligating adaptors to one or more targets in the sample.

### Claim 9

A kit for linear amplification of a least one nucleic acid target in a sample comprising a primer comprising modification blocking the primer from being copied by the polymerase and an exonuclease blocker.

### Claim 10 (depends on 9)

The kit of claim 9, wherein the modification is a quadruplex forming sequence.

### Claim 11 (depends on 9)

The kit of claim 9, wherein the modification is selected from a group consisting of a modified base, a modified nucleotide and a modified backbone.

### Claim 12 (depends on 9)

The kit of claim 9, wherein the exonuclease blocker is a phosphorothioate nucleotide.

### Claim 13 (depends on 9)

The kit of claim 9, wherein the primer further comprises one or more universal primer binding sites.

### Claim 14 (depends on 9)

The kit of claim 9, further comprising a facilitating enzyme selected from a group consisting of recombinase, helicase, exonuclease and nicking endonuclease.

### Claim 15 (depends on 9)

The kit of claim 9, further comprising a duplex disruption reagent selected from a group consisting of a single-strand binding protein (SSB), DMSO, Proline and betaine.
